Literature DB >> 17964024

Advances in radiation therapy for brain tumors.

Volker W Stieber1, Minesh P Mehta.   

Abstract

Radiation therapy is used postoperatively as adjunctive therapy to decrease local failure; to delay tumor progression and prolong survival; as a curative treatment; as a therapy that halts further tumor growth; to alter function; and for palliation. Registration of MRI scan data sets with the treatment-planning CT scan is essential for accurate definition of the tumor and surrounding organs at risk. Integrating additional imaging studies that reflect the biologic characteristics of central nervous system tumors is an area of active research. Conformal treatment delivery is used to spare adjacent normal tissue from receiving unnecessary dose. In the dose range used when treating these tumors, the probability of causing serious late toxicity is relatively low and secondary malignancies are rare.

Entities:  

Mesh:

Year:  2007        PMID: 17964024     DOI: 10.1016/j.ncl.2007.07.005

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  9 in total

Review 1.  Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma.

Authors:  Erwin G Van Meir; Costas G Hadjipanayis; Andrew D Norden; Hui-Kuo Shu; Patrick Y Wen; Jeffrey J Olson
Journal:  CA Cancer J Clin       Date:  2010 May-Jun       Impact factor: 508.702

Review 2.  Imaging hypoxia in gliomas.

Authors:  I Mendichovszky; A Jackson
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

Review 3.  Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target.

Authors:  Randy L Jensen
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

4.  Glioblastoma multiforme.

Authors:  Herbert B Newton
Journal:  Curr Treat Options Neurol       Date:  2008-07       Impact factor: 3.598

5.  Tissue pO2 of orthotopic 9L and C6 gliomas and tumor-specific response to radiotherapy and hyperoxygenation.

Authors:  Nadeem Khan; Hongbin Li; Huagang Hou; Jean P Lariviere; David J Gladstone; Eugene Demidenko; Harold M Swartz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-01-10       Impact factor: 7.038

Review 6.  An EGFRvIII-targeted bispecific T-cell engager overcomes limitations of the standard of care for glioblastoma.

Authors:  Patrick C Gedeon; Bryan D Choi; Tiffany R Hodges; Duane A Mitchell; Darell D Bigner; John H Sampson
Journal:  Expert Rev Clin Pharmacol       Date:  2013-07       Impact factor: 5.045

7.  Antitumor activity of dichloroacetate on C6 glioma cell: in vitro and in vivo evaluation.

Authors:  Yu Duan; Xin Zhao; Wei Ren; Xin Wang; Ke-Fu Yu; Dan Li; Xuan Zhang; Qiang Zhang
Journal:  Onco Targets Ther       Date:  2013-03-14       Impact factor: 4.147

8.  Radioprotective Effect of Aminothiol PrC-210 on Irradiated Inner Ear of Guinea Pig.

Authors:  Arnaud P J Giese; Jess G Guarnaschelli; Jonette A Ward; Daniel I Choo; Saima Riazuddin; Zubair M Ahmed
Journal:  PLoS One       Date:  2015-11-23       Impact factor: 3.240

9.  Assessing the Effects of Software Platforms on Volumetric Segmentation of Glioblastoma.

Authors:  William D Dunn; Hugo J W L Aerts; Lee A Cooper; Chad A Holder; Scott N Hwang; Carle C Jaffe; Daniel J Brat; Rajan Jain; Adam E Flanders; Pascal O Zinn; Rivka R Colen; David A Gutman
Journal:  J Neuroimaging Psychiatry Neurol       Date:  2016-07-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.